OQROGet OQRO Pro
Politician trade (House)

Cencora (COR)Rep. Jared Moskowitz (FL23) disclosed a sale $1K–$15K

Rep. Jared Moskowitz (FL23) disclosed a sale of Cencora in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
44 days
Disclosure lag
Traded
May 6, 2026
Disclosed
Jun 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 2, 2026Federal contract · $4.3M obligatedDepartment of Defense awarded Cencora: $4.34M obligated to date
  2. Feb 3, 2026Federal contract · $4.9M obligatedDepartment of Defense awarded Cencora: $4.93M obligated to date
  3. Feb 18, 2026Federal contract · $5.2M obligatedDepartment of Defense awarded Cencora: $5.18M obligated to date
  4. Feb 18, 2026Federal contract · $4.8M obligatedDepartment of Defense awarded Cencora: $4.79M obligated to date
  5. Mar 11, 2026Federal contract · $9.0M obligatedDepartment of Defense awarded Cencora: $9.01M obligated to date
  6. Mar 16, 2026FDARecall: Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed…
  7. Mar 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 17, 2026, Cencora, Inc. (the “Company”) announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer of the Company effective June 30, 2026.”
  8. Mar 23, 2026Congress · 1 personMembers of Congress: 2 purchases
  9. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  10. Mar 27, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
  11. Mar 31, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
  12. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
  13. May 1, 2026FDARecall: Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Ca…
  14. May 1, 2026FDARecall: Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. C…
  15. May 6, 2026 · this disclosureCongressDisclosed sale of COR — reported range $1,001 - $15,000

What came next

  1. May 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. May 6, 2026CongressDisclosed sale of COR — reported range $1,001 - $15,000
  3. May 13, 2026Federal contract · $4.5M obligatedDepartment of Defense awarded Cencora: $4.5M obligated to date
  4. May 13, 2026Federal contract · $4.3M obligatedDepartment of Defense awarded Cencora: $4.25M obligated to date
  5. May 23, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”).”
  6. May 28, 2026Federal contract · $4.2M obligatedDepartment of Defense awarded Cencora: $4.24M obligated to date
  7. May 28, 2026Insider · Largest insider buy since 2006Director purchased ~$1.07M of COR shares in the open market
  8. Jun 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026.”
  9. Jun 12, 2026Federal contract · $7.7M obligatedDepartment of Defense awarded Cencora: $7.74M obligated to date
  10. Jun 18, 2026InsiderDirector purchased ~$1.1M of COR shares in the open market
  11. Jun 22, 2026Insider · Their first buy on recordDirector purchased ~$149K of COR shares in the open market
  12. Jul 31, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  13. Aug 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  14. Aug 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 13, 2026, following the conclusion of the quarterly meeting of the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”), Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately.”
  15. Aug 20, 2026Federal contract · $39K obligatedDepartment of Veterans Affairs awarded Cencora: $39K obligated to date
  16. Aug 24, 2026Insider · Their largest sale since 2022Officer sold ~$3.66M of COR shares in the open market
  17. Sep 1, 2026InsiderOfficer sold ~$321K of COR shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Rep. Jared Moskowitz (FL23)

The full history of Rep. Jared Moskowitz (FL23) is on the profile page.

How this filing works

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data